Home › Liver Cancer › NCT05517811
Pre- and Post-operative TEG Indices in Patients With or Without Adenocarcinoma Undergoing Surgical Resection
Use of Viscoelastic Assays Beyond Coagulation: Pre- and Post-operative TEG
Who can join
Ages 18 to 99 · All sexes · Healthy volunteers welcome
Full eligibility criteria
Inclusion Criteria: * new diagnosis by the providing physician of hepatopancreaticobiliary, esophageal, colorectal, lung adenocarcinoma, or liver metastasis of any origin will be eligible for enrollment in the study * 18 Years and older Exclusion Criteria: * Under 18 years old * prisoners * unable to provide informed consent * pregnant women * and those undergoing emergent or urgent operative intervention at the time of diagnosis
About the study
The investigators hypothesize that abnormalities in thromboelastography (TEG) parameters in patients with liver, pancreas, biliary, esophageal, colorectal, and lung adenocarcinoma can serve as biomarkers for oncologic disease burden, cancer recurrence and overall survival as well as thrombotic and hemorrhagic post-operative complications. The investigators further hypothesize that there is histologic pathology correlates to pre-operative TEG abnormalities, and that it identifies patients with virulent tumor biology.
What is being tested
- TEG indices (diagnostic test)
Sponsor: University of Colorado, Denver · Participants: 200 · Started: Jun 26, 2022
Contact the study team
- Tracey MacDermott, BA BS CCRC · Phone: 303-724-2757
Official record on ClinicalTrials.gov — NCT05517811
Locations in the U.S.
| Colorado | University of Colorado Denver, Aurora UCHealth Highlands Ranch Hospital, Highlands Ranch |
Conditions
- Liver Cancer
- Esophageal Cancer
- Colorectal Cancer
- Adenocarcinoma of Lung
- Pancreatic Cancer
- Biliary Tract Cancer
From ClinicalTrials.gov, data retrieved Sep 29, 2026. Each study sets its own eligibility; the study team decides who can join.